This summary was created by AI, based on 10 opinions in the last 12 months.
Astera Labs (ALAB) has garnered attention due to its strong positioning in the hyperscaler market, appealing to major players in cloud technology. Several experts suggest that the stock has experienced significant volatility following its IPO, which priced at $32 but fluctuated to the $80s before settling back into the $50s and $60s. Most analysts view ALAB as a promising investment due to its ability to optimize data transfer and processing within the cloud, potentially making it a solid buy as it approaches more favorable price levels, like $100 or lower. However, caution is advised with some experts recommending a wait-and-see approach given the recent high valuations. The consensus is that despite current fluctuations, ALAB is a company with potential for future growth, particularly in the ever-expanding AI and cloud infrastructure sectors.
In the semiconductor space, you could probably look a little further down the food chain. Loves this one. Small. Favourite for a lot of the giants. Works inside the cloud to make chips more efficient. Makes the data in data centres run faster on less energy.
IPO'd only 2 months ago at $38. Don't put a lot of money in, just a small position. Can buy here at $72-73, and in the low $60s. Doesn't think it will go much below that. Will be a star performer in the years ahead. In the AI trend on the infrastructure side.
IPO at beginning of March. Priced at $32, opened at $58, shot up into the $80s, dropped into $60s with the general pullback. Still a bargain. Data-centric. Lets software companies connect quickly with the cloud, other software, and other networks. 12-month price target of $86, but can be sure that will be raised as it approaches. No dividend.
Put 3-5% of your portfolio in this, be well rewarded.
Is up 136% since IPO'ing on March 20, and it's probably overheated. ALAB is positioning itself as a new way to play the AI theme. The valuation was high right from the start Trye, sales growth was 45% last year, but they had negative earnings and negative operating cash flow last year. Operating income turned positive in Q3 and net income went positive in Q4; keep that eye and they will turn positive later this year. Also, another company could develop a better technology than theirs in a year.
Astera Labs is a American stock, trading under the symbol ALAB-Q on the NASDAQ (ALAB). It is usually referred to as NASDAQ:ALAB or ALAB-Q
In the last year, 10 stock analysts published opinions about ALAB-Q. 7 analysts recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Astera Labs.
Astera Labs was recommended as a Top Pick by on . Read the latest stock experts ratings for Astera Labs.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
10 stock analysts on Stockchase covered Astera Labs In the last year. It is a trending stock that is worth watching.
On 2025-04-23, Astera Labs (ALAB-Q) stock closed at a price of $60.15.
Quite the ride. There were so many stock options to sell, that stock went below IPO price. Then stock rocketed up, but got caught up in tariffs. Hold on, but you have to respect the price target.